McKesson
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
McKesson scored a 100 out of 100 on the 2023-2024 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, McKesson increases the risk of dividing employees, alienating customers and harming shareholders. The company provides a benefits package for employees which covers transgender medical procedures for covered employees and dependents, including children. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. McKesson forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. McKesson was sued by a former employee who alleged that she was fired for refusing the coronavirus vaccine on religious grounds, but the company denies this allegation. The company supports the Equality Act. McKesson’s public affairs team monitors legislation in conjunction with LGBTQ and ally employees "that could significantly impact the LGBT community". Senate Democrats sent a letter to McKesson and other top pharmaceutical companies asking them to clarify or share plans surrounding the dispensement of mifepristone, an FDA-approved abortion pill. McKesson has not clarified its position. CEO Brian Tyler is a member of the Business Roundtable and signed its 2019 Statement on the Purpose of a Corporation, which promotes stakeholder capitalism over traditional obligations to shareholders. McKesson has frequently used its website to promote LGBTQ as one's "true identity". The company opposed various state and local legislation intended to protect parental rights, girls’ sports, bathroom facilities, and gendered spaces. McKesson's CEO, Brian S. Tyler, signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace. The company developed a curriculum that “confronts impact of unconscious bias and mitigate it”. McKesson is a copper sponsor of Out & Equal and is a sponsor of Dallas Pride. For these reasons, McKesson receives a High Risk rating.
View Full Corporate Bias Ratings ReportBoard Bias
Expand Summary
CEO of McKesson
Brian S. Tyler
Summary:
Headquartered in Irving, Texas, McKesson is a member of the Fortune 250 operating in the Health Care Equipment and Services industry. Brian S. Tyler and Donald R. Knauss serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $145,100 to Republican causes and $714,740 to Democratic causes. Under their tenure, McKesson currently holds a 'High Risk' risk rating.
View Full Board Bias ReportPolitical Contributions of Leadership:
$145,100
$714,740
Republican
Democrat
Shareholder Proposals
Expand Summary
Date | ESG Category | Proponent | Summary of Resolution | Mgmt Rec | Total Vote % in Favor |
---|---|---|---|---|---|
5/16/24 | Environmental | As You Sow | Report on Scope 3 GHG Emissions Reporting | Against | 28.10% |
5/16/24 | Social | Arjuna Capital | Shareholder Proposal on Pay Gap Reporting | Against | 26.51% |
7/21/23 | Governance | John Chevedden | Ratification of Termination Pay | Against | 10.80% |
5/17/23 | Environmental | As You Sow | Report on GHG Emissions Financing | Against | 28.90% |
5/17/23 | Social | Domini Impact Investments LLC | Report on Human Rights Risk Assessment | Against | 16.50% |
7/22/22 | Governance | NYC Comptroller's Office | Adopt Policy on 10b5-1 Plans | Against | 49.34% |
7/22/22 | Governance | John Chevedden | Special Meetings - Reduce Ownership Req. to 10% | Against | 36.91% |
5/19/22 | Social | As You Sow | Report on Efforts to Reduce Greenhouse Gas Emissions Associated with Underwritin, Insuring, and Investing | Against | 72.18% |
5/19/22 | Social | Green Century Capital Management | Policy Restricting Underwriting of New Fossil Fuel Supplies | Against | 19.38% |
In the News
Expand Summary
Walmart , Amazon , Exxon Mobil , Apple , UnitedHealth Group , CVS Health , Berkshire Hathaway , Alphabet , McKesson , Chevron